Changes in Beneficial Ownership · 4
TransMedics Group, Inc.
TMDXNASDAQEQUITYCurrent
Changes in Beneficial Ownership
Structured filing — 4
ownership.xml
Filing details
- Report period
- 2026-05-20
- Issuer
- TransMedics Group, Inc.
- Issuer CIK
- 0001756262
- Trading symbol
- TMDX
Reporting owner 1
- Name
- Lovell Stephanie
- Reporting owner CIK
- 0001772054
- Relationship
- Director
- Address
- C/O TRANSMEDICS GROUP, INC., 200 MINUTEMAN ROAD, ANDOVER, MA, 01810
Non-derivative transactions
| Security | Transaction date | Code | Amount | A / D | Price (USD) | Owned after | Ownership |
|---|---|---|---|---|---|---|---|
| Common Stock | 2026-05-20 | A · Form 4 | 2,922[F1] | A | 0 | 5,788 | D |
Table key
- A · Form 4
- Acquisition by grant, award or otherwise under Rule 16b-3(d)
- A
- Acquired
- D
- Direct
Footnotes
- F1
- Consists of 2,922 restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock.↩ 1
Signature 1
- Signed
- By: /s/ Gerardo Hernandez, Attorney-in-Fact
- Date
- 2026-05-22
Company context
TransMedics is the world’s leader in portable extracorporeal warm perfusion and assessment of donor organs for transplantation. Headquartered in Andover, Massachusetts, the company was founded to address the unmet need for more and better organs for transplantation and has developed technologies to preserve organ quality, assess organ viability prior to transplant, and potentially increase the utilization of donor organs for the treatment of end-stage heart, lung, and liver failure. TransMedics routinely posts information that may be important to investors on the landing page of the Company's website and in the "Investors" section of the website at https://investors.transmedics.com/. Investors and potential investors are encouraged to consult the TransMedics website regularly for important information about TransMedics.